Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EVH 
Evolent Health Inc (EVH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $15.46
1 Year Target Price $15.46
| 9 | Strong Buy |
| 4 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.69% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 873.26M USD | Price to earnings Ratio - | 1Y Target Price 15.46 |
Price to earnings Ratio - | 1Y Target Price 15.46 | ||
Volume (30-day avg) 14 | Beta 0.66 | 52 Weeks Range 7.06 - 25.22 | Updated Date 10/18/2025 |
52 Weeks Range 7.06 - 25.22 | Updated Date 10/18/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.6 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.94% | Operating Margin (TTM) 0.64% |
Management Effectiveness
Return on Assets (TTM) -0.21% | Return on Equity (TTM) -11.04% |
Valuation
Trailing PE - | Forward PE 18.87 | Enterprise Value 1617210255 | Price to Sales(TTM) 0.4 |
Enterprise Value 1617210255 | Price to Sales(TTM) 0.4 | ||
Enterprise Value to Revenue 0.74 | Enterprise Value to EBITDA 185.35 | Shares Outstanding 115971135 | Shares Floating 91317991 |
Shares Outstanding 115971135 | Shares Floating 91317991 | ||
Percent Insiders 1.54 | Percent Institutions 108.82 |
Upturn AI SWOT
Evolent Health Inc
Company Overview
History and Background
Evolent Health was founded in 2011. It partners with health plans and providers to improve clinical and financial outcomes by providing population health management and integrated care solutions.
Core Business Areas
- Evolent Care Partners: Partners with health systems and provider groups to enhance care management and population health programs.
- New Century Health: Specialty care management for oncology and cardiology, providing comprehensive care management programs.
- Evolent Health Plan Services: Offers a suite of administrative and technology services for health plans, including risk adjustment and quality improvement.
Leadership and Structure
Evolent Health's leadership team is headed by John Johnson (CEO). The company has a structured management hierarchy with various functional departments including operations, finance, and technology.
Top Products and Market Share
Key Offerings
- Evolent Care Partners Solutions: Comprehensive population health management services, focusing on care coordination, analytics, and technology platforms. Evolent does not break out revenue specifically for ECP. Competitors include Optum (UNH), CareSource, and various regional provider-sponsored health plans.
- New Century Health Oncology & Cardiology Management: Specialized care management solutions that offer medical oncologists and cardiologists access to care management tools to help manage complex populations. Evolent does not break out revenue specifically for NCH. Competitors include AIM Specialty Health (Anthem) and Magellan Healthcare (CVS).
- Identifi: Data and analytics platform for population health management, providing insights to improve care delivery. Evolent does not break out revenue specifically for Identifi. Competitors include Innovaccer and Arcadia.
Market Dynamics
Industry Overview
The healthcare technology and services industry is growing, driven by the shift to value-based care, increasing demand for healthcare services, and technological advancements.
Positioning
Evolent Health positions itself as a partner to health plans and providers, offering integrated solutions to improve clinical and financial outcomes in the value-based care environment. Their competitive advantage lies in their integrated solutions, including population health management tools and New Century Health.
Total Addressable Market (TAM)
The TAM for healthcare IT and value-based care solutions is estimated to be in the hundreds of billions of dollars. Evolent is positioned to capture a portion of this market through its partnerships and solutions.
Upturn SWOT Analysis
Strengths
- Strong partnerships with health plans and providers
- Comprehensive and integrated care management solutions
- Specialty care management capabilities (New Century Health)
- Technology platform for population health management (Identifi)
Weaknesses
- Reliance on key client relationships
- Profitability concerns despite revenue growth
- Competition from larger, more established players
- Dependence on the shift to value-based care
Opportunities
- Expanding into new geographic markets
- Acquiring additional healthcare technology companies
- Developing new solutions for specific populations
- Leveraging data and analytics to improve care outcomes
Threats
- Changes in healthcare regulations
- Increasing competition from new entrants
- Economic downturn affecting healthcare spending
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- UNH
- CVS
- HUM
Competitive Landscape
Evolent Health faces competition from larger, more established players. Their strength lies in its integrated solutions and specialty care management capabilities, but its dependence on partnerships and profitability concerns remain challenges.
Major Acquisitions
Vital Decisions
- Year: 2018
- Acquisition Price (USD millions): 55
- Strategic Rationale: Expanded Evolent's care management capabilities into advance care planning.
New Century Health
- Year: 2018
- Acquisition Price (USD millions): 200
- Strategic Rationale: Acquisition of New Century Health enhanced Evolent's specialty care management capabilities in oncology and cardiology, providing comprehensive care management programs.
Growth Trajectory and Initiatives
Historical Growth: Evolent Health has experienced significant revenue growth in recent years, driven by its partnerships and acquisitions.
Future Projections: Future growth is projected to be driven by the continued shift to value-based care and the company's ability to expand its solutions and partnerships.
Recent Initiatives: Recent initiatives include expanding its specialty care management capabilities and investing in its technology platform.
Summary
Evolent Health is a growing healthcare company focusing on value-based care solutions through partnerships and technology. Its strengths lie in integrated solutions and specialty care management. Challenges include profitability and competition. Future growth depends on the shift to value-based care and successful expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry News
- Company Website
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4500 | Website https://www.evolent.com |
Full time employees 4500 | Website https://www.evolent.com | ||
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.